Lenalidomide API

Name	Lenalidomide
Chinese name	来那度胺
Cas Number	191732-72-6
Source	India
Qualifications	USDMF/-/-/-/-

Lenalidomide is an analog of thalidomide, which has immunomodulatory, anti-angiogenic and anti-tumor properties. Approved by the FDA at the end of 2005, it is clinically used for multiple myeloma and myelodysplastic syndromes. It has now surpassed first-line treatment drugs such as bortezomib to become the world's TOP1 drug for the treatment of multiple myeloma. One of the three magic drugs". In 2016, global lenalidomide sales reached US$6.974 billion, with a compound growth rate of 102%; in the first quarter of 2017, lenalidomide sales were US$1.884 billion, a year-on-year increase of 19.7%. On July 19, 2017, lenalidomide was included in China's Class B medical insurance, which will quickly make lenalidomide a well-deserved first-line drug for multiple myeloma. The market will be greatly increased in the future, and Lisheng will definitely Become a blockbuster product in the anti-tumor industry.

Hot Tags: lenalidomide api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Valganciclovir Hydrochloride API, Pregabalin API, Perindopril Tert butylamine Salt API, Pabxilib API, Apremilast API, Tippyridine Hydrochloride API

• Previous: Isodiazep API
• Next: Fluticasone Furoate API